Haplo Life Sciences Private Limited

Haplo Life Sciences Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2020PTC373068 Incorporated 11 November 2020 ROC Delhi HQ Delhi, India
Active Private Limited Company healthcare
Revenue · FY 2025
₹19.38 Lakh
▼ 65% YoY
Net loss · FY 2025
₹22,210
Net margin -1.1%
EBITDA · FY 2025
-₹22,210
EBITDA margin -1.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Haplo Life Sciences Private Limited

Data last updated:

Haplo Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 11 November 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2020PTC373068. Its GSTIN is 07AAFCH5388A1ZN (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Karuna Upadhyay and Dinesh Chandra Upadhyay.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. S – 3 S/F Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078.

As per the financials filed for FY 2025, the company reported a revenue of ₹19.38 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹22,210 (net margin -1.1%) and EBITDA of -₹22,210 (EBITDA margin -1.1%).

Company details

CIN U51397DL2020PTC373068
Registration Number 373068
Incorporation Date 11 November 2020
ROC Delhi
Listing Status Unlisted
Company Status Active

Contact details

Haplo Life Sciences Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No. S – 3 S/F Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Haplo Life Sciences Private Limited, buy the company report.

Comprehensive company report
Haplo Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Haplo Life Sciences is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Haplo Life Sciences Private Limited, buy the company report.

Financials of Haplo Life Sciences Private Limited

FY 2025 filings available

Haplo Life Sciences Private Limited reported revenue of ₹19.38 Lakh (down 65% YoY) for FY 2025.

Revenue · FY 2025
₹19.38 Lakh ▼ 65%
Net loss · FY 2025
₹22,210 margin -1.1%
EBITDA · FY 2025
-₹22,210 margin -1.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 65%
EBITDA CAGR growth
1 year
▼ 263%
3 years · compounded
▼ 1%

Revenue fell 65% in the latest year. EBITDA fell 263% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹22,210
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹22,210
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-1.1%
Net Profit Margin-1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Haplo Life Sciences Private Limited, buy the company report.

Board of directors of Haplo Life Sciences Private Limited

Haplo Life Sciences has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Karuna UpadhyayDirector11 Nov 20206 Years 0 MonthsCurrent
Dinesh Chandra UpadhyayDirector11 Nov 20206 Years 0 MonthsCurrent

Peer comparison

Haplo Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Eilis Health Care Private Limited₹19.49 Lakh (FY 2023)-22.0%Mumbai, Maharashtra, India
Haplo Life Sciences Private Limitedthis company₹19.38 Lakh (FY 2025)-₹22,210-1.1%-65.0%Delhi, India
Vego & Thomson Infra-Tech (India) Private Limited₹19.37 Lakh (FY 2025)-92.0%Jhajjar, Haryana, India
New Sound Hearing Aid Private Limited₹19.29 Lakh (FY 2025)-95.0%Delhi, India

To see the full peer comparison of Haplo Life Sciences Private Limited, buy the company report.

Auditor

Haplo Life Sciences Private Limited is audited by GHANSHYAM SURESH GUPTA & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
GHANSHYAM SURESH GUPTA & ASSOCIATESFY 2023026525N

Shareholding

The shareholding of Haplo Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Haplo Life Sciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Haplo Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Haplo Life Sciences Private Limited has 1 active EPFO establishment as of Nov 12, 2026.

Active EPFO establishments
1

GST

Haplo Life Sciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAFCH5388A1ZNDelhiActive03 Dec 2020

To see the full GST registrations and return filing status of Haplo Life Sciences Private Limited, buy the company report.

Recent activity

Haplo Life Sciences Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Dinesh Chandra Upadhyay was appointed as Director on 11 Nov 2020.

AGM
Haplo Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Haplo Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Dinesh Chandra Upadhyay was appointed as Director.
Appointed
Karuna Upadhyay was appointed as Director.
Incorporation
11 Nov 2020
Haplo Life Sciences Private Limited was registered on 11 Nov 2020 with Roc Delhi I & aged 6 years 5 days as per MCA records.

Frequently asked questions

Haplo Life Sciences is an active private limited company based in Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 11 November 2020 (6+ years old) and is registered under CIN U51397DL2020PTC373068.

Haplo Life Sciences has 2 current directors:

The latest financial statements of Haplo Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Haplo Life Sciences is 07AAFCH5388A1ZN, registered in Delhi.

The CIN (Corporate Identification Number) of Haplo Life Sciences is U51397DL2020PTC373068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Haplo Life Sciences was incorporated on 11 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Haplo Life Sciences by revenue are Eilis Health Care Private Limited, Vego & Thomson Infra-Tech (India) Private Limited, New Sound Hearing Aid Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).

Dinesh Chandra Upadhyay was appointed as Director on 11 Nov 2020. Karuna Upadhyay was appointed as Director on 11 Nov 2020.

The registered office of Haplo Life Sciences is at Shop No. S – 3 SF Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078.

Haplo Life Sciences operates in the healthcare industry, in the diagnostic centers and pathology labs segment.

Haplo Life Sciences can be reached at its registered office: Shop No. S – 3 SF Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078.